Ypsomed
Roman Wüthrich is an accomplished professional in innovation and business development, currently serving as Associate Director at Ypsomed AG since September 2020. In this role, Roman is instrumental in shaping the innovation roadmap, analyzing market environments, and formulating customer needs, while managing sub-projects and acquiring partnerships with pharmaceutical companies. Previous experience includes roles as Business Development Manager, Product Manager at Hamilton Bonaduz AG, and Mechanical Design Engineer at Brooks Life Science Systems. Roman’s educational background includes an MBA from the University of Basel and a Bachelor's in Mechanical Engineering from Berner Fachhochschule BFH, complemented by relevant vocational training in mechanical design. Roman has also contributed to the formation of two patents and has a military service background with the Swiss Armed Forces.
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.